Royal Philips (NYSE:PHG) said it won 510(k) clearance from the FDA for its IQon Spectral CT system for enhanced computed tomography imaging.

“Through the Spectral CT scan, clinicians can access the conventional grey-scale anatomical images, along with the spectral information within the same scan. As a result, Philips IQon Spectral CT enables real-time, retrospective data analysis, without disrupting a clinician’s workflow and takes the guesswork out of multi-energy acquisitions, making it easy to use and allowing for routine spectral use,” the Dutch company said in a press release.

The IQon Spectral CT system is available in 36 nations, according to the release. Philips said it plans to showcase the product at the annual meeting of the Radiological Society of North America, slated for Nov. 30 to Dec. 5 in Chicago.

In September, Philips said it plans to spin out its legacy lighting business and merge Philips Healthcare and its consumer business into a new ‘HealthTech’ unit.

Earlier this month, the company agreed to sell its InnerCool temperature-management business to Zoll Medical for an unspecified amount.